Search
Ivabradine
go.drugbank.com/drugs/DB09083ApprovedInvestigationalIvabradine, brand name Corlanor, was approved by the FDA in April 2015 for the treatment of chronic heart failure in patients with an ejection fraction of ≤35%, in sinus rhythm with resting heart rate
Products: IVABALAN 5MG FTA, IVABALAN 7.5MG FTAEntecavir
go.drugbank.com/drugs/DB00442ApprovedInvestigationalFood and Drug Administration (FDA) in March 2005.
Products: BARACLUDE 1MG FTA, BARACLUDE 0.5MG FTAAnakinra
go.drugbank.com/drugs/DB00026ApprovedInvestigationalAnakinra is a recombinant human interleukin-1 (IL-1) receptor antagonist (IL-1Ra) composed of 153 amino acid residues. … On November 14, 2001, it was approved by the FDA for the treatment of rheumatoid arthritis.
Categories: Interleukin-1 Receptor AntagonistSynonyms: IL-1RA, Interleukin-1 receptor antagonist anakinraEtoricoxib
go.drugbank.com/drugs/DB01628ApprovedInvestigationalWithdrawnEtoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inh...
Products: ARCOXIA 30MG FTA, ARCOXIA 90MG FTALeflunomide
go.drugbank.com/drugs/DB01097ApprovedInvestigationalLeflunomide was approved by FDA and in many other countries (e.g., Canada, Europe) in 1999.
Products: ARAVA 10 MG FTA, ARAVA 20MG FTAOlmesartan
go.drugbank.com/drugs/DB00275ApprovedInvestigationalOlmesartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes [telmisartan], [candesartan], [losartan], [valsartan], and [irbesartan]. … The angiotensin II receptor blocker (ARB) family of drugs unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized.
Mixtures: SEVIKAR 20MG/5MG FTA, SEVIKAR 20MG/5MG FTACategories: Angiotensin 2 Receptor Blocker, Angiotensin Receptor AntagonistsSolifenacin
go.drugbank.com/drugs/DB01591ApprovedInvestigational[L7511] Solifenacin was granted FDA approval on 19 November 2004.[L7511] … Solifenacin is a competitive muscarinic receptor antagonist indicated to treat an overactive bladder with urinary incontinence, urgency, and frequency.
Products: BELMACINA 5MG FTA, SOLIFEMIN 5MG FTAIrbesartan
go.drugbank.com/drugs/DB01029ApprovedInvestigational[L7456,L7459] Irbesartan was granted FDA approval on 30 September 1997.[L7456,L7459] … Irbesartan is an angiotensin receptor blocker (ARB) indicated to treat hypertension or diabetic nephropathy.
Mixtures: DIOGENA-DRACategories: Angiotensin 2 Receptor Blocker, Angiotensin II receptor antagonistsAzathioprine
go.drugbank.com/drugs/DB00993ApprovedInvestigational[L11214] Azathiprine was granted FDA approval on 20 March 1968.[L11214]
Products: AZATHIOPRIN AL 25MG FTA, AZATHIOPRIN AL 50MG FTALamivudine
go.drugbank.com/drugs/DB00709ApprovedInvestigationalA reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV).
Products: EPIVIR 300MG FTA, LAMIVUDIN TEVA 150MG FTA